Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Passing a bronchoscope through the airways frequently causes a stress response even though
patients are sedated. This stress response is usually an increase in pulse and blood
pressure, which may have undesirable effects on the heart and circulation.
We plan to give patients labetalol (a beta blocker which reduces pulse and blood pressure) in
addition to normal sedation, to patients undergoing bronchoscopy in our department.